Skip to main content

9 June 2023

Last updated: Monday 29 May 2023

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Why pharma is paying a premium for assets

Sunday 18 March 2018

Interviewee/Contributor

Tim Sturgeon and Martin Gouldstone

Organisation

Results Healthcare

Organisations

Chroma Therapeutics Ltd
Adrenomed AG
European Patent Office
Celtic Pharma Holdings
Humabs BioMed SA
Bellevue Asset Management
OrgaNext Research BV
Edmond de Rothschild Partners
Allero Therapeutics BV
Provecs Medical GmbH

Interviewees and Contributers

Andy Smith
Rosie Bannister
Richard Godfrey
Philippe Pouletty
John Lambert
Sander Slootweg
Vittore Tamassia and Bruno Pagliara
William Ellington
Christian Wandersee
David Moller

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Sphere Fluidics appoints new chairman

Thursday 25 May 2023

Jason Slingsby becomes CBO at LifeArc

Thursday 25 May 2023

Walter Miller becomes CFO at Heidelberg Pharma

Thursday 25 May 2023

Ingrid Rauter named CMO at Vaccentis

Thursday 25 May 2023

Enterome forms scientific advisory board

Thursday 25 May 2023

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2023 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form